Serghei Chercheja and Peter Eilbracht
FULL PAPERS
calculated for C9H16O2: C 69.19, H10.32; found: C 68.96, H
the mixture of syn/anti diastereomers (1.5:1) of the title
compound as a colourless oil (yield: 615 mg, 83%). Diaste-
10.60. IR (filM): nmax =3435, 2952, 2868, 1709, 1360 cmÀ1
;
[a]2D0: +45.7 (c 1.00, n-heptane); HPLC: CHIRALPAK AD,
n-heptane/i-PrOH, 98.2:1.8, 1.0 mLminÀ1, 280 nm, ee=81%:
tR (major)=19.1 min; tR (minor)=20.7 min.
reomers were separated on
column (EtOAc/cyclohexane, 1:6).
(4R,5R)-4-Hydroxy-5-phenylhexan-2-one (7a): 1HNMR
a semi-preparative HPLC
AHCTREUNG
1
(Z)-4-Cyclopentylbut-3-en-2-one (4): HNMR (400 MHz,
(500 MHz, CDCl3): d=7.32–7.29 (m, 2H), 7.24–7.16 (m,
3H), 4.09 (ddd, 1H, J=7.9, 5.8, 5.8 Hz), 2.74 (qd, 1H, J=
7.9, 7.0 Hz), 2.42–2.40 (m, 2H), 2.07 (s, 3H), 1.36 (d, 3H,
J=7.0 Hz); 13C NMR (100 MHz, CDCl3): d=17.6, 30.7, 45.4,
47.9, 72.1, 126.6, 127.6, 128.6, 143.8, 210.1, in accord with the
literature data;[17] HR-MS (FAB+): exact mass calculated
for [M+H]+ (C12H17O2) requires m/z=193.1229, found:
m/z=193.1236; elemental analysis (%), calculated for
C12H16O2: C 74.97, H8.39; found: C 74.48, H8.50; IR
(film): nmax =3461, 2965, 1708, 1493, 1452, 1361, 1164, 702
cmÀ1; [a]2D0: +13.8 (c 1.23, n-heptane); HPLC: CHIRAL-
PAK AD, n-heptane/i-PrOH, 98:2, 1.0 mLminÀ1, 254 nm,
ee=72%: tR (major)=14.9 min; tR (minor)=15.8 min.
CDCl3): d=6.76 (dd, 1H, J=16.0, 8.0 Hz), 6.03 (d, 1H, J=
16.0 Hz), 2.61–2.54 (m, 1H), 2.30 (s, 3H), 1.89–1.21 (m, 8H),
in accord with the literature data.[16]
(R)-4-Cycloheptyl-4-hydroxybutan-2-one (5): Purified
using column chromatography (EtOAc/cyclohexane, 1:4) to
afford the title compound as a colourless oil (yield: 337 mg,
1
47%). HNMR (400 MHz, CDCl 3): d=3.91–3.87 (m, 1H),
2.92 (d, 1H, J=2.8 Hz), 2.60–2.48 (m, 2H), 2.16 (s, 3H),
1.86–1.17 (m, 13H); 13C NMR (100 MHz, CDCl3): d=26.7,
26.9, 28.2, 29.2, 29.8, 30.8, 44.1, 46.6, 71.8, 210.5; HR-MS
(FAB+): exact mass calculated for [M+H]+ (C11H21O2) re-
quires m/z=185.1542, found: m/z=185.1565; elemental
analysis (%), calculated for C11H20O2: C 71.70, H10.94;
found: C 71.46, H11.10; IR (film) nmax =3435, 2921, 2854,
1709, 1358 cmÀ1; [a]D20: +50.8 (c 1.00, n-heptane); HPLC:
CHIRALPAK AD, n-heptane/i-PrOH, 98:2, 1.0 mLminÀ1,
280 nm, ee=89%: tR (major)=15.7 min; tR (minor)=
18.9 min.
(4R,5S)-4-Hydroxy-5-phenylhexan-2-one (7b): 1HNMR
(500 MHz, CDCl3): d=7.34–7.31 (m, 2H), 7.26–7.22 (m,
3H), 4.20 (ddd, 1H, J=9.3, 6.1, 2.6 Hz), 2.82 (qd, J=7.0,
6.1 Hz), 2.58 (dd, 1H, J=17.2, 2.6 Hz), 2.47 (dd, 1H, J=
17.2, 9.3 Hz), 2.14 (s, 3H), 1.31 (d, 3H, J=7.0 Hz);
13C NMR (125 MHz, CDCl3): d=17.0, 30.8, 45.0, 47.3, 71.7,
126.6, 128.1, 128.4, 142.8, 209.4, in accord with the literature
data;[17] HR-MS (FAB+): exact mass calculated for [M+
H]+ (C12H17O2) requires m/z=193.1229, found: m/z=
193.1236; elemental analysis (%), calculated for C12H16O2: C
74.97, H8.39; found: C 74.62, H8.60; IR (film): nmax =3461,
2965, 1708, 1493, 1452, 1361, 1164, 702 cmÀ1; [a]D20: +32.7 (c
1.97, n-heptane); HPLC: CHIRALCEL OJ, n-heptane/i-
PrOH, 90:10, 1.0 mLminÀ1, 254 nm, ee >99%: tR =13.4 min.
5-(4-Chlorophenyl)-4-hydroxyhexan-2-one
(6a,
b)
(Table 5, entry 1): Purified using column chromatography
(EtOAc/cyclohexane, 1:4) to afford the mixture of syn/anti
diastereomers (1.5:1) of the title compound as a colourless
oil (yield: 0.786 g, 89%). The diastereomers were separated
on a semi-preparative HPLC column (EtOAc/cyclohexane,
1:6).
A
1HNMR (500 MHz, CDCl 3): d=7.29–7.26 (m, 2H), 7.21–
7.11 (m, 2H), 4.06 (dddd, 1H, J=7.8, 5.8, 5.8, 3.8 Hz), 3.13
(d, 1H, J=3.8 Hz), 2.73 (qd, 1H, J=7.8, 7.0 Hz), 2.41–2.39
(m, 2H), 2.08 (s, 3H), 1.33 (d, 3H, J=7.0 Hz); 13C NMR
(100 MHz, CDCl3): d=17.3, 30.8, 44.3, 47.4, 71.4, 128.4,
129.5, 132.3, 141.4, 209.4; HR-MS (FAB+): exact mass cal-
culated for [M+H]+ (C12H16ClO2) requires m/z=227.0839,
found: m/z=227.0822; elemental analysis (%), calculated
for C12H15ClO2: C 63.58, H6.67; found: C 63.39, H6.90; IR
(film): nmax =3464, 2964, 2927, 1711, 1492, 1411, 1360, 1091,
1012, 828 cmÀ1; [a]2D0: +17.8 (c 1.60, n-heptane); HPLC:
CHIRALPAK AD, n-heptane/i-PrOH, 98:2, 1.0 mLminÀ1,
230 nm, ee=72%: tR (major)=16.0 min; tR (minor)=
17.3 min.
C
A
(6b):
1HNMR (500 MHz, CDCl 3): d=7.30–7.26 (m, 2H), 7.21–
7.18 (m, 2H), 4.17 (ddd, 1H, J=9.2, 6.00, 2.8 Hz), 2.78 (qd,
1H, J=7.2, 6.0 Hz), 2.58 (dd, 1H, J=17.3, 2.8 Hz), 2.43 (dd,
1H, J=17.3, 9.2 Hz), 2.14 (s, 3H), 1.29 (d, 3H, J=7.2 Hz);
13C NMR (125 MHz, CDCl3): d=17.3, 30.8, 44.3, 47.4, 71.4,
128.4, 129.5, 132.3, 141.4, 209.4; HR-MS (FAB+): exact
mass calculated for [M+H]+ (C12H16ClO2) requires m/z=
227.0839, found: m/z=227.0822; elemental analysis (%),
calculated for C12H15ClO2: C 63.58, H6.67; found: C 63.45,
H6.90; IR (film): nmax =3464, 2964, 2927, 1711, 1492, 1411,
1360, 1091, 1012, 828 cmÀ1; [a]2D0: +45.4 (c 1.00, n-heptane);
HPLC: CHIRALCEL OJ, n-heptane/i-PrOH, 97:3,
0.5 mLminÀ1, 230 nm, ee >99%: tR =16.0 min.
4-Hydroxy-5-phenylhexan-2-one (7a,b): Purified using
column chromatography (EtOAc/cyclohexane, 1:4) to afford
1904
ꢀ 2007 Wiley-VCHVerlag GmbH& Co. KGaA, Weinheim
Adv. Synth. Catal. 2007, 349, 1897 – 1905